Bioequivalence and Bioavailability Forum • No, sorry

No, sorry [Design Issues]

posted by Pharma_88 – India, 2024-05-20 08:50 (203 d 20:02 ago) – Posting: # 24002
Views: 2,486

Dear Ohlbe,

Thank you for response. Could you please let me know how the parallel design will be planned?

As per my understanding...
Screening >> Stabilization Period (with the approved product) >> Randomization (T/R) >> EOS

Regards,
Pharma_88

—
Regards,
Pharma_88

Complete thread:

Single dose PK study on Patients Pharma_88 2024-05-15 05:37 [Design Issues]
- Single dose PK study on Patients Ohlbe 2024-05-15 09:39
  - Single dose PK study on Patients Pharma_88 2024-05-17 10:06
    - No, sorry Ohlbe 2024-05-17 13:45
      - No, sorryPharma_88 2024-05-20 06:50
        
        Deviating from a guidance Helmut 2024-05-20 07:57
        
        Deviating from a guidance Pharma_88 2024-05-21 08:32
        
        No, sorry Ohlbe 2024-05-21 12:41